Fredun Pharmaceuticals Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Fredun Pharmaceuticals Ltd is ₹ 2310 as of 12 Jun 15:30 . The P/E Ratio of Fredun Pharmaceuticals Ltd is 0 as of March 2023 .The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023 . The Market Cap of Fredun Pharmaceuticals Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023 . The revenue of Fredun Pharmaceuticals Ltd for the Mar '26 is ₹ 213.06 crore as compare to the Dec '25 revenue of ₹ 160.92 crore. This represent the growth of 32.4% The revenue of Sandu Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Fredun Pharmaceuticals Ltd for the Mar '26 is ₹ 28.88 crore as compare to the Dec '25 ebitda of ₹ 26.34 crore. This represent the growth of 9.64% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Fredun Pharmaceuticals Ltd changed from ₹ 13.74 crore to ₹ 10.78 crore over 6 quarters. This represents a CAGR of -14.93% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Fredun Pharmaceuticals Ltd changed from 13.9 % on March 2021 to 1.59 % on March 2025 . This represents a CAGR of -35.18% over 5 yearsThe Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 years .

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94.
The Company was promoted by Nariman Medhora and Daulat N Medhora.
The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Limited (SPL) was established in 1987.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.

FAQs for the comparison of Fredun Pharmaceuticals Ltd and Sandu Pharmaceuticals Ltd

Which company has a larger market capitalization, Fredun Pharmaceuticals Ltd or Sandu Pharmaceuticals Ltd?

Market cap of Fredun Pharmaceuticals Ltd is 1,273 Cr while Market cap of Sandu Pharmaceuticals Ltd is 40 Cr

What are the key factors driving the stock performance of Fredun Pharmaceuticals Ltd and Sandu Pharmaceuticals Ltd?

The stock performance of Fredun Pharmaceuticals Ltd and Sandu Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fredun Pharmaceuticals Ltd and Sandu Pharmaceuticals Ltd?

As of June 14, 2026, the Fredun Pharmaceuticals Ltd stock price is INR ₹2310.75. On the other hand, Sandu Pharmaceuticals Ltd stock price is INR ₹41.61.

How do dividend payouts of Fredun Pharmaceuticals Ltd and Sandu Pharmaceuticals Ltd compare?

To compare the dividend payouts of Fredun Pharmaceuticals Ltd and Sandu Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.